Financials
- Market Capitalization 4.1 B
- Employee 137
- Founded 2017
- CEO N/A
- Website www.tangotx.com
- Headquarter Delaware, United States
- FIGI BBG00WFDDRS0
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-10.18
ratio cours/chiffre d'affaires
16.5
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1436 | ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 25.50 USD | -2.75% | -2.52% | +20.85% | +16.23% | 4.37 B USD | ||
| 1463 | DNLI Denali Therapeutics Inc. - Common Stock | 26.48 USD | +3.12% | +2.12% | +21.13% | +63.76% | 4.20 B USD | ||
| 1527 | NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 33.28 USD | -5.62% | -5.00% | +6.74% | -8.24% | 3.89 B USD | ||
| 1535 | CPRX Catalyst Pharmaceuticals, Inc. - Common Stock | 31.48 USD | +0.03% | -0.03% | +0.38% | +48.42% | 3.85 B USD |